aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Christine Hall
February 15, 2024
.406 Ventures, a Boston-based venture firm investing in enterprise-focused startups in healthcare, data and AI, and cybersecurity, closed its fifth fund with $265 million in capital commitments.
The firm was founded by Liam Donohue, who was the founder of Boston venture firm Arcadia Partners, and two other partners, including Maria Cirino, co-founder of the managed-security services company Guardent, and former Razorfish CFO Larry Begley.
The new fund is backed by a group of new and existing limited partners, including university endowments, foundations, pension plans and strategic investors. Including the new fund, the 18-year-old firm has raised more than $1.4 billion across its five core funds and three opportunity funds.
It’s been awhile since TechCrunch caught up with the firm. Speaking recently with Donohue, he said .406 Ventures’ focus hasn’t changed much during that time. The firm continues to invest in those same three industries and leverages the Boston tech ecosystem, though it does invest nationally.
However, unlike some of the firm’s previous funds, Donohue is seeing more repeat founders coming back for new investments.
“We wanted to be a partner so that a founder would come back to us for their next thing,” Donohue told TechCrunch. “In funds one and two, we had a couple of repeat founders. In the more recent funds, I’m excited to see so many great repeat partners coming back that a third of the fourth fund was repeat founders, and I’d expect about the same in fund five.”
Over the two decades, the firm has put together a portfolio of 87 companies, many of which have exited or gone public. Most recently those have included Iora Health, acquired by OneMedical in 2021 and now part of Amazon Health. Behavioral health company AbleTo is under Optum Health. Meanwhile, Carbon Black and CloudHealth Technologies are part of VMware while cybersecurity insurance company Corvus was acquired by Travelers in 2023.
.406 Ventures has already made investments in four companies from the new fund, including Portrait Analytics, the developer of a generative AI platform for investment research and thesis creation. It will invest in more than 20 companies with the new fund, Donohue said.
When looking at startups within the three verticals of healthcare, data and AI, and cybersecurity, the firm considers a number of factors, like the plan for infrastructure, especially now that AI is everywhere. It also taps into executive councils of over 100 C-suite operators from Fortune 500 companies.
“We ask ourselves, ‘What are the new technologies that are either going to need to be protected or will enhance and change the threat factors?’ Donohue said. “We’re always looking forward three to five years and anticipating where the vulnerabilities are going to be and then who is building the protections for this.”
View original article on techcrunch.com
Share:
Global crypto firms turn to Hong Kong for refuge — and opportunity
With U.S. regulators continuing to ramp up scrutiny, crypto startups and founders are looking to Hong Kong to support their growth. © 2024 TechCrunch. All rights reserved. For personal use only.
May 6, 2024
DocuSign acquires AI-powered contract management firm Lexion
As DocuSign reportedly explores a sale to private equity, it’s acquiring a company itself. On Monday, DocuSign (which now prefers to go by Docusign, with a lowercase “S,” a PR rep from the company tells me) announced that it’s buying Lexion, a contract workflow automation startup, for $165 million. The purchase comes as DocuSign makes increasing investments […] © 2024 TechCrunch. All rights reserved. For personal use only.
May 6, 2024
TechCrunch Minute: Newchip, Techstars and what happens when startup accelerators fail
Building a startup is hard. Building a company that helps startups is similarly difficult. That’s the takeaway from TechCrunch reporting on Techstars and Newchip. In the case of Newchip, the accelerator appeared to promise a bit more than it could deliver. Mix in a culture that appeared to be turbulent at best, and you have […] © 2024 TechCrunch. All rights reserved. For personal use only.
May 6, 2024
Don't miss our latest news and updates. Subscribe to the newsletter